Caricamento...
Neoantigen Vaccines Pass the Immunogenicity Test
Neoantigens arising from tumor-specific genomic alterations constitute authentic “non-self” antigens and represent a new class of targets for cancer immunotherapy. Recent reports on various vaccine platforms targeting neoantigens suggest a basis for precision therapies customized to each patient’s t...
Salvato in:
| Pubblicato in: | Trends Mol Med |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624828/ https://ncbi.nlm.nih.gov/pubmed/28867556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmed.2017.08.007 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|